TLSA today
$0.58-$0.03 (-4.55%)close Nov 13, 2026Trend
DailyDowntrend (starting)
4 hourStrong Bearish
1 hourStrong Bearish
15 minStrong Bearish
5 minStrong Bearish
Daily trend turns up above $2.60
Key levels
Resistance$0.80
Resistance$0.70
Support$0.57
Support$0.41
Latest news & SEC filings
ProductTiziana Life Sciences reports Phase 2a INFORM-MS results for intranasal foralumab in secondary progressive MS
All TLSA news →About Tiziana Life Sciences
Tiziana Life Sciences is a clinical-stage biotechnology company working on therapies for cancer and immune system disorders. Its main candidate is a lab-made antibody that blocks a specific immune signaling receptor, and it is being tested in neurological conditions such as multiple sclerosis, Alzheimer's disease, ALS, and multiple system atrophy. The company runs its operations through subsidiaries in Bermuda, the United States, the United Kingdom, and Italy.
Based on the company's 20-F filed May 1, 2026.
Nasdaq · Healthcare
Tiziana Life Sciences Ltd (TLSA)
What Is the Price Target for TLSA?
SEPT Low Target
$5.95
SEPT Mid Target
$7.00
SEPT High Target
$8.05
Analyst Consensus
$7.00
Is TLSA a Buy or Sell Right Now?
Thesis
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for TLSA.
Start Free Trial →Is TLSA Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, PEG, Analyst Consensus
Fair Value
$5.00
7
Moat Score
NONE
2/9
Piotroski Score
-18.0
Altman Z-Score
What Is Smart Money Doing with TLSA?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Elrifi Ivor | officer | Buy | 1,050,000 | - | Aug 15, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →TLSA Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
35.29%
FCF Growth YoY
90.1%
Revenue Trend
UNKNOWN
Dark Pool Trades for TLSA
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for TLSA, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 18:55:16 | $0.59 | 2,200 | $$1K | BUY |
| 18:14:40 | $0.59 | 1,084 | $$636 | SELL |
| 17:49:52 | $0.58 | 7,000 | $$4K | SELL |
| 17:23:25 | $0.59 | 1,500 | $$887 | BUY |
| 17:07:32 | $0.60 | 1,000 | $$599 | BUY |
5 dark pool trades shown · $$7K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for TLSA
PREVIEWSEPT Investing provides real-time options flow tracking for TLSA, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $5 | Nov 20 | 7 | $$125 | 1 | SWEEP |
1 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Tiziana Life Sciences Ltd (TLSA) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →TLSA — frequently asked questions
What is TLSA stock price today?
Tiziana Life Sciences Ltd (TLSA) is at $0.58, down 4.55% (-$0.03) at the Nov 13, 2026 close.
Why is TLSA stock moving today?
Latest TLSA news — Nov 9, 2026: Tiziana Life Sciences reports Phase 2a INFORM-MS results for intranasal foralumab in secondary progressive MS
What is the TLSA price target?
The average analyst price target for TLSA is $7.00, ranging from $7 to $7, based on 2 analysts. Latest: Tiziana Life Sciences upgrade on Sep 3, 2026.
What do analysts rate TLSA?
Analyst ratings for TLSA: 0 Buy, 2 Hold, 0 Sell — consensus Hold.
Did TLSA beat earnings?
TLSA last reported on Oct 16, 2026: EPS -$0.08 vs -$0.08 expected — a miss of 2.3%.
Does TLSA pay a dividend?
TLSA does not currently pay a dividend.
How much debt does TLSA have?
Tiziana Life Sciences Ltd reported $0M of debt and $4M of cash (Dec 31, 2024).
What are TLSA support and resistance levels?
Support: $0.57, $0.41. Resistance: $0.70, $0.80, $0.94.
What are insiders doing with TLSA?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on TLSA?
Nov 9, 2026: Tiziana Life Sciences reports Phase 2a INFORM-MS results for intranasal foralumab in secondary progressive MS